TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible” January 13, 1984
TCL Archive Rauscher Tabs Oak Ridge Immunologists To Head Basic Research At Frederick August 30, 1974